المؤلفون: Johanssen, T, McVeigh, L, Erridge, S, Higgins, G, Straehla, J, Frame, M, Aittokallio, T, Carragher, NO, Ebner, D

المساهمون: Helsinki Institute for Information Technology, Tero Aittokallio / Principal Investigator, Bioinformatics, Institute for Molecular Medicine Finland, University of Helsinki, Research Programs Unit, Helsinki Institute of Life Science HiLIFE

المصدر: Johanssen, T, Mcveigh, L, Erridge, S, Higgins, G, Straehla, J, Frame, M, Aittokallio, T, Carragher, N O & Ebner, D 2023, ' Glioblastoma and the search for non-hypothesis driven combination therapeutics in academia ', Frontiers in Oncology, vol. 12 . https://doi.org/10.3389/fonc.2022.1075559

مصطلحات موضوعية: Cancer Research, Temozolamide, glioblastoma stem cell, Radiotherapy, drug targer combination, hypoxia, high throughput screening (HTS), 3122 Cancers, glioblastoma, radiothereapy, Oncology, temozolamide, Glioblastoma stem cell, Glioblastoma, Hypoxia, Drug target combination

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80e8f9cd4c4055006f05c987ad669b76
https://www.pure.ed.ac.uk/ws/files/321563058/Glioblastoma_and_the_search_for_non_hypothesis_driven_combination_therapeutics_in_academia_Review.pdf

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.